Bullfrog AI Holdings, Inc. (NASDAQ:BFRG – Get Free Report) saw a significant growth in short interest in September. As of September 30th, there was short interest totalling 318,100 shares, a growth of 59.4% from the September 15th total of 199,600 shares. Based on an average daily trading volume, of 205,000 shares, the short-interest ratio is presently 1.6 days. Approximately 6.0% of the shares of the stock are sold short.
Insiders Place Their Bets
In related news, CEO Vininder Singh sold 14,405 shares of the business’s stock in a transaction dated Tuesday, October 1st. The shares were sold at an average price of $2.65, for a total value of $38,173.25. Following the completion of the transaction, the chief executive officer now owns 2,478,041 shares of the company’s stock, valued at approximately $6,566,808.65. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Over the last 90 days, insiders sold 31,603 shares of company stock valued at $82,989. Corporate insiders own 33.90% of the company’s stock.
Institutional Inflows and Outflows
Several large investors have recently modified their holdings of the stock. Fortem Financial Group LLC acquired a new position in Bullfrog AI during the first quarter worth approximately $171,000. Renaissance Technologies LLC purchased a new stake in shares of Bullfrog AI during the 2nd quarter valued at $34,000. Finally, XTX Topco Ltd acquired a new stake in shares of Bullfrog AI during the 2nd quarter worth $32,000. 0.96% of the stock is currently owned by hedge funds and other institutional investors.
Bullfrog AI Price Performance
Bullfrog AI (NASDAQ:BFRG – Get Free Report) last released its earnings results on Wednesday, August 7th. The company reported ($0.20) EPS for the quarter.
About Bullfrog AI
Bullfrog AI Holdings, Inc, through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform for the analysis of preclinical and/or clinical data.
Read More
- Five stocks we like better than Bullfrog AI
- What is a SEC Filing?
- Whirlpool’s High Dividend Yield Is Too Good to Pass Up
- Why is the Ex-Dividend Date Significant to Investors?
- Holiday Spending Boom Ahead: 3 BNPL Stocks Poised for Gains
- What Investors Need to Know About Upcoming IPOs
- Boeing: A Perfect Storm of Trouble Is a Loaded Buying Opportunity
Receive News & Ratings for Bullfrog AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bullfrog AI and related companies with MarketBeat.com's FREE daily email newsletter.